Alamar Biosciences Reports Q2 Revenue of $29.4M (+82% YoY), Guides FY2026 Revenue to $116M–$120M
ALMR sits 54% above its 52-week low of $18.845.
Summary
Alamar Biosciences posted Q2 2026 revenue of $29.4 million, an 82% increase year-over-year, and guided for full-year revenue of $116–$120 million. Gross margins improved to 60%, and the company ended the quarter with $250 million in cash.
Key Events · Earnings and Guidance · ALMR
-
Q2 Revenue Surges 82%
Total revenue reached $29.4 million in Q2 2026, up from $16.2 million in Q2 2025, driven by a 147% increase in consumables revenue to $15.5 million and a 35% increase in instrument revenue to $7.8 million.
-
Full-Year 2026 Guidance Initiated
Management guided for full-year 2026 revenue of $116 million to $120 million, representing approximately 100% growth at the midpoint over 2025.
-
Gross Margin Expands to 60%
Gross margin improved to 60% in Q2 2026 from 53% in Q2 2025, reflecting manufacturing efficiencies and a favorable shift toward higher-margin consumables.
-
Strong Balance Sheet with $250M in Cash
Cash, cash equivalents and short-term investments totaled $250.1 million as of June 30, 2026, following $197.8 million in net IPO proceeds, providing ample runway for growth investments.
Analysis · ALMR · Industrial Applications And Services
Alamar Biosciences delivered strong Q2 results with revenue nearly doubling year-over-year, driven by rapid consumables pull-through and instrument placements. Gross margins expanded to 60% as manufacturing efficiencies kicked in. The company initiated full-year 2026 revenue guidance of $116M–$120M, implying ~100% growth at the midpoint. While net losses widened on heavy R&D and SG&A investment, the balance sheet is fortified with $250M in cash and equivalents post-IPO, and a new $60M revolving credit facility provides additional liquidity. The stock is trading near its 52-week high, reflecting market confidence in the growth trajectory.
At the time of this filing, ALMR was trading at $28.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $18.85 to $29.43. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.